Total Payments
$68,118
2024 Payments
$2,102
Companies
29
Transactions
333
Medicare Patients
4,215
Medicare Billing
$827,533
Payment Breakdown by Category
Other$62,950 (92.4%)
Food & Beverage$5,126 (7.5%)
Education$41.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,950 | 21 | 92.4% |
| Food and Beverage | $5,126 | 309 | 7.5% |
| Education | $41.49 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $65,019 | 125 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $571.82 | 40 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $443.31 | 27 | $0 (2022) |
| Genentech USA, Inc. | $347.36 | 24 | $0 (2019) |
| Electromed, Inc. | $269.20 | 33 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $184.50 | 11 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $181.83 | 7 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $181.16 | 15 | $0 (2020) |
| United Therapeutics Corporation | $140.85 | 7 | $0 (2019) |
| ABIOMED | $109.93 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,102 | 4 | GlaxoSmithKline, LLC. ($1,950) |
| 2023 | $17,143 | 7 | GlaxoSmithKline, LLC. ($17,143) |
| 2022 | $27,901 | 20 | GlaxoSmithKline, LLC. ($27,851) |
| 2021 | $13,587 | 26 | GlaxoSmithKline, LLC. ($13,456) |
| 2020 | $4,218 | 43 | GlaxoSmithKline, LLC. ($3,746) |
| 2019 | $1,217 | 98 | GlaxoSmithKline, LLC. ($272.88) |
| 2018 | $885.83 | 62 | GlaxoSmithKline, LLC. ($271.34) |
| 2017 | $1,063 | 73 | GlaxoSmithKline, LLC. ($328.96) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $42.01 | General |
| Category: PULMONOLOGY | ||||||
| 09/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $109.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 04/26/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 04/12/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $124.54 | General |
| 03/15/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 02/28/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $118.42 | General |
| 02/22/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 02/01/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| 11/09/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 10/25/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $97.91 | General |
| 10/12/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 10/12/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 10/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 09/28/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 09/27/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 07/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.93 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 799 | 1,746 | $280,369 | $174,377 |
| 2022 | 12 | 1,018 | 2,390 | $337,314 | $215,301 |
| 2021 | 12 | 886 | 2,248 | $289,374 | $203,856 |
| 2020 | 16 | 1,512 | 2,797 | $384,656 | $233,999 |
Total Patients
4,215
Total Services
9,181
Medicare Billing
$827,533
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 268 | 721 | $90,112 | $62,333 | 69.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 154 | 373 | $106,528 | $60,167 | 56.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 195 | 467 | $40,155 | $28,587 | 71.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 143 | 146 | $37,700 | $19,414 | 51.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $2,290 | $1,506 | 65.8% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 11 | 11 | $2,090 | $1,239 | 59.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 11 | 11 | $1,494 | $1,132 | 75.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 311 | 977 | $110,187 | $75,502 | 68.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 169 | 401 | $112,790 | $68,069 | 60.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 192 | 643 | $55,920 | $35,155 | 62.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 153 | 155 | $36,176 | $23,329 | 64.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 44 | $6,050 | $3,388 | 56.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 19 | 22 | $4,361 | $2,500 | 57.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $4,010 | $2,382 | 59.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 28 | $3,186 | $2,189 | 68.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 29 | 32 | $1,919 | $1,203 | 62.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 29 | 32 | $1,479 | $882.33 | 59.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 20 | 23 | $1,098 | $592.59 | 54.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 11 | 11 | $138.49 | $108.81 | 78.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 236 | 827 | $88,332 | $68,843 | 77.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 124 | 315 | $90,571 | $56,732 | 62.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 179 | 703 | $56,803 | $40,291 | 70.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 103 | 106 | $21,919 | $16,578 | 75.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 103 | $13,722 | $9,364 | 68.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 48 | 48 | $5,123 | $4,063 | 79.3% |
About Dr. Michael Perkins, M.D
Dr. Michael Perkins, M.D is a Internal Medicine healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659472017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Perkins, M.D has received a total of $68,118 in payments from pharmaceutical and medical device companies, with $2,102 received in 2024. These payments were reported across 333 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,950).
As a Medicare-enrolled provider, Perkins has provided services to 4,215 Medicare beneficiaries, totaling 9,181 services with total Medicare billing of $827,533. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Savannah, GA
- Active Since 09/26/2006
- Last Updated 05/10/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659472017
Products in Payments
- TRELEGY ELLIPTA (Drug) $23,783
- ANORO ELLIPTA (Drug) $3,699
- ANORO (Drug) $366.15
- SMARTVEST (Device) $269.20
- SYMBICORT (Drug) $263.05
- DUPIXENT (Biological) $197.40
- Xolair (Biological) $189.82
- BREO (Drug) $161.65
- Esbriet (Biological) $157.54
- FASENRA (Drug) $154.82
- OFEV (Drug) $145.82
- ORENITRAM (Drug) $140.85
- SPIRIVA RESPIMAT (Drug) $132.36
- NUCALA (Biological) $117.46
- Impella (Device) $109.93
- BEVESPI AEROSPHERE (Drug) $107.45
- STIOLTO (Drug) $101.71
- LONHALA MAGNAIR (Drug) $95.70
- UPTRAVI (Drug) $84.01
- UTIBRON (Drug) $65.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Savannah
Dr. Jennifer Woehler, D.o, D.O
Internal Medicine — Payments: $183,589
Internal Medicine $183,589
Paul Bradley, Md, MD
Internal Medicine — Payments: $33,506
Internal Medicine $33,506
John Demicco, M.d, M.D
Internal Medicine — Payments: $32,210
Internal Medicine $32,210
Dr. Timothy Connelly, Md, MD
Internal Medicine — Payments: $24,711
Internal Medicine $24,711
Wilfredo Dolor, Md, MD
Internal Medicine — Payments: $20,320
Internal Medicine $20,320
Thomas Hogan, Md, MD
Internal Medicine — Payments: $18,153
Internal Medicine $18,153